Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 This is with reference to CDSL's Operating Instructions for Issuers/RTAs, which states that the Issuer/RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, we would like to inform you that no share has been dematerialized during the month of January, 2022. A copy of the certificate obtained from the Company's RTA viz. Skyline Financial Services Pvt. Ltd., regarding shares dematerialized as on January 31, 2022 is also enclosed herewith
03-02-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of the newspaper advertisements regarding Notice of EGM, Cut-off Date and Remote E-voting information published on February 03, 2022 in the following newspapers:- Business Standard - All Editions; and Desh Sewak - Punjabi Edition
03-02-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Board Meeting Intimation for For Approving The Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter And Nine Months Ended December 31, 2021

 PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31, 2021. Further, pursuant to Regulation 46(2) of the SEBI LODR Regulations, notice of the said meeting is also being uploaded on the website of the Company. Further, with reference to our earlier announcement dated December 31, 2021 intimating the Closure of Trading Window pursuant to the Company''s Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all Designated Persons of the Company till February 16, 2022 and the same will re-open from February 17, 2022.
03-02-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Extraordinary General Meeting ('EGM') Of The Company Is Scheduled To Be Held On Saturday, February 26, 2022 At 11:30 A.M. Through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM')

 We would like to state that an EGM of the Company is scheduled to be held on Saturday, February 26, 2022 at 11:30 A.M. through VC / OAVM in terms of the Circulars issued by the Ministry of Corporate Affairs and SEBI from time to time. Further, relating to the EGM of the Company, you are requested to take note of the following: 1. For the purpose of exercising remote e-voting, the cut-off date shall be Saturday, February 19, 2022. 2. The remote e-voting period shall commence on Wednesday, February 23, 2022 (from 09:00 a.m. IST) and end on Friday, September 25, 2022 (upto 05:00 p.m. IST). 3. Remote e-Voting facility will also be available during the EGM for the members attending the EGM. In regard to the above, a copy of Notice of the EGM being sent to the shareholders through email is enclosed herewith for your reference.
01-02-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Read With SEBI Circular Dated September 09, 2015

 We would like to inform that the Board of the Company in its meeting held on February 01, 2022 had: taken on record the resolution passed by the Company's wholly-owned subsidiary for sale, transfer or disposal of its domestic business assets constituting its pharmaceutical formulations brands in India and Nepal including related trademarks, copyrights and such other intellectual property as may be agreed, inventories, etc. to Mankind Pharma Limited ('Buyer') and/or subsidiaries of Buyer and the Binding Term Sheet executed by the Company, the Seller and the Buyer in this regard; and approved the said Transaction. In the said meeting, the Board had also convened an EGM of the Company on Saturday, February 26, 2022 at 11.30 AM through Video Conferencing / Other Audio-Visual Means. The meeting of the Board of Directors commenced at 11:30 A.M. and concluded at 12:15 P.M.
01-02-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Board Meeting Outcome for Intimation Under Regulation 29 And 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Read With SEBI Circular Dated September 09, 2015

 We would like to inform that the Board of Directors in its meeting held on 01.02.200 had: taken on record the resolution passed by the Company's wholly-owned subsidiary for sale, transfer or disposal of its domestic business assets constituting its pharmaceutical formulations brands in India and Nepal including related trademarks, copyrights and such other intellectual property as may be agreed, inventories, etc. to Mankind Pharma Limited ('Buyer') and/or subsidiaries of Buyer; and approved the said Transaction. In the said meeting, the Board had also convened an Extra-ordinary General Meeting of the Company on Saturday, February 26, 2022 at 11.30 AM through Video Conferencing / Other Audio-Visual Means. The meeting of the Board of Directors commenced at 11:30 A.M. and concluded at 12:15 P.M.
01-02-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Board Meeting Intimation for Considering And Approving The Proposal Of Raising Funds

 PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2022 ,inter alia, to consider and approve the proposal of raising funds in such manner and on such terms as may be decided by the Board of Directors of the Company and / or its subsidiary company, subject to such regulatory /statutory approvals as may be required. The Board would also consider convening Extra-ordinary General Meeting of its shareholders for seeking their approval in accordance with the relevant provisions of the Act. Further, the trading window of the Company is already closed for all Designated Persons of the Company from January 01, 2022 and shall continue to remain closed till completion of 48 hours from the announcement to the Stock Exchanges regarding Unaudited financial results of the Company for the quarter and nine months ended December 31, 2021.
25-01-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to bring to your kind notice that the a shareholder has reported to the Company about loss of his Share Certificate and has requested for issuance of duplicate Share Certificate in lieu of the lost Share Certificate. The said shares have already been transferred to Investor Education and Protection Fund Authority (IEPF Authority). Therefore, the Company will not issue any duplicate share certificate in lieu thereof and will confirm his entitlement for the said shares. The details of the said shares are attached herewith
18-01-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Shareholding for the Period Ended December 31, 2021

 Panacea Biotec Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
10-01-2022
Bigul

PANACEA BIOTEC LTD. - 531349 - Statement Of Investor Complaints For The Quarter Ended December 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Vinod GoelDesignation :- Company Secretary and Compliance Officer
10-01-2022
Next Page
Close

Let's Open Free Demat Account